U.S. Invests $3 Billion to Accelerate Antiviral Medicines

In COVID-19, Latest News by Precision Vaccinations

The U.S. government announced it is investing more than $3 billion to accelerate the discovery, development, and manufacturing of antiviral medicines as part of the whole-of-government strategy to develop the next generation of COVID-19 treatments. 

Read More